Skip to main content
. 2022 Jan 18;327(3):227–236. doi: 10.1001/jama.2021.23605

Figure 3. Effect of Randomization to a P2Y12 Inhibitor on the Time to the Event for the Composite Outcome of Organ Support or Death in Non–Critically Ill Patients With COVID-19.

Figure 3.

Kaplan-Meier curve for the time to event of respiratory or cardiovascular organ support or death. All patients were followed up until death or 28 days. The time to organ support or death in patients assigned to a P2Y12 inhibitor vs usual care was not significantly different (26% vs 22%, respectively; adjusted hazard ratio, 1.19 [95% CI, 0.84-1.68], P = .34). The time to the event was compared post hoc using Cox regression.